Title : Aztreonam/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019.

Pub. Date : 2021 Feb 11

PMID : 33276387






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Aztreonam/avibactam is under clinical development for treatment of serious infections caused by Gram-negative bacteria, including MBL-producers. Aztreonam mannose-binding lectin family member 3, pseudogene Homo sapiens
2 CONCLUSIONS: Our results support clinical development of aztreonam/avibactam to treat infections caused by Enterobacterales, including MBL-producers. Aztreonam mannose-binding lectin family member 3, pseudogene Homo sapiens